Cargando…
Three Novel EGFR Mutations (750_758del, I759S, T751_I759delinsS) in One Patient with Metastatic Non-Small Cell Lung Cancer Responding to Osimertinib: A Case Report
Generations of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) can significantly improve the outcome of EGFR-positive NSCLC patients. However, acquired TKIs-resistant mutations are inevitable. Except the common EGFR alterations, more and more rare mutations are revealed by ne...
Autores principales: | Li, Huiying, Yu, Tingting, Lin, Yongjuan, Xie, Yu, Feng, Jie, Huang, Mingmin, Guo, Aibin, Liu, Xiangyu, Yin, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493011/ https://www.ncbi.nlm.nih.gov/pubmed/32982275 http://dx.doi.org/10.2147/OTT.S259616 |
Ejemplares similares
-
Afatinib and osimertinib in lung adenocarcinoma harbored
EGFR
T751_I759delinsS mutation: A case report
por: Fang, Yueh‐Fu, et al.
Publicado: (2021) -
EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC
por: Chang, Zi-Ting, et al.
Publicado: (2022) -
The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports
por: Meng, Yamin, et al.
Publicado: (2023) -
R.C.P. 759 : Excitations Non-linéaires
Publicado: (1987) -
Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking
por: Erlenhardt, Nadine, et al.
Publicado: (2020)